The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
On September 19, 2024, the Food and Drug Administration approved amivantamab-vmjw with carboplatin and pemetrexed…
Spiritual beliefs and a historically-based distrust of clinical research may factor into Black patients’ decisions…
On September 27, 2024, the Food and Drug Administration granted traditional approval to selpercatinib for…
Glioblastoma is the most common and most aggressive primary brain tumour, with an average survival…
A cancer study has found that certain gut bacteria may influence whether or not a…
Immune checkpoint blockade (ICB) is one of the primary methods of tumour immunotherapy. It involves reactivating…
When it comes to cancer metastasis, it takes two to tango. That was one of…
The risk of skin cancer, malignant melanoma, now appears to be decreasing in Sweden -…
Researchers at the University of Michigan Health Rogel Cancer Center, USA, have uncovered a key…
Phase 2 results from the NeoCOAST-2 study demonstrated that the combination of durvalumab with Dato-DXd…